Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Anticancer Res. 2022 Sep;42(9):4529-4533. doi: 10.21873/anticanres.15955.
BACKGROUND/AIM: Many patients with locally advanced cancer of the esophagus or esophagogastric junction receive definitive or neoadjuvant radiochemotherapy. Patient anticipation of this treatment can cause or aggravate distress and sleep disorders. This study aimed to identify the prevalence of sleep disorders and risk factors.
Thirty-eight patients assigned to radio-chemotherapy were retrospectively evaluated for pre-treatment sleep disorders. Investigated characteristics included age; sex; performance score; comorbidity index; previous malignancies; family history; distress score; emotional, physical or practical problems; tumor site; histology and grading; tumor stage; planned treatment; and relation to 2019 Coronavirus pandemic.
Sleep problems were reported by 15 patients (39.5%). Significant associations were found for higher distress scores (p=0.016) and greater numbers of emotional problems (p<0.0001). A trend was observed for greater numbers of physical problems (p=0.176).
The prevalence of sleep problems was high. Risk factors were found that can help identify patients requiring psychological support already prior to radio-chemotherapy.
背景/目的:许多局部晚期食管癌或食管胃交界癌患者接受根治性或新辅助放化疗。患者对这种治疗的预期可能导致或加重痛苦和睡眠障碍。本研究旨在确定睡眠障碍的患病率和危险因素。
回顾性评估了 38 例接受放化疗的患者的治疗前睡眠障碍。调查的特征包括年龄;性别;表现评分;合并症指数;既往恶性肿瘤;家族史;痛苦评分;情绪、身体或实际问题;肿瘤部位;组织学和分级;肿瘤分期;计划治疗;以及与 2019 年冠状病毒病的关系。
15 名患者(39.5%)报告存在睡眠问题。较高的痛苦评分(p=0.016)和更多的情绪问题(p<0.0001)与睡眠问题显著相关。身体问题的数量也存在增加的趋势(p=0.176)。
睡眠问题的患病率很高。发现了一些危险因素,可以帮助在放化疗前识别需要心理支持的患者。